ArticleAmerican journal of translational research2021

Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways.

Lingli Huang et al.PubMed ↗Full text ↗

No numbers read from the abstract.